153 related articles for article (PubMed ID: 31302345)
1. Confirmation of thermal dose as a predictor of local control in cervical carcinoma patients treated with state-of-the-art radiation therapy and hyperthermia.
Kroesen M; Mulder HT; van Holthe JML; Aangeenbrug AA; Mens JWM; van Doorn HC; Paulides MM; Oomen-de Hoop E; Vernhout RM; Lutgens LC; van Rhoon GC; Franckena M
Radiother Oncol; 2019 Nov; 140():150-158. PubMed ID: 31302345
[TBL] [Abstract][Full Text] [Related]
2. The Effect of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in 400 Locally Advanced Cervical Carcinoma Patients.
Kroesen M; Mulder HT; van Holthe JML; Aangeenbrug AA; Mens JWM; van Doorn HC; Paulides MM; Oomen-de Hoop E; Vernhout RM; Lutgens LC; van Rhoon GC; Franckena M
Front Oncol; 2019; 9():134. PubMed ID: 30906734
[No Abstract] [Full Text] [Related]
3. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia.
Franckena M; Fatehi D; de Bruijne M; Canters RA; van Norden Y; Mens JW; van Rhoon GC; van der Zee J
Eur J Cancer; 2009 Jul; 45(11):1969-78. PubMed ID: 19361982
[TBL] [Abstract][Full Text] [Related]
4. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy.
Rijkmans EC; Nout RA; Rutten IH; Ketelaars M; Neelis KJ; Laman MS; Coen VL; Gaarenstroom KN; Kroep JR; Creutzberg CL
Gynecol Oncol; 2014 Nov; 135(2):231-8. PubMed ID: 25172763
[TBL] [Abstract][Full Text] [Related]
5. Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: data from a multicentre randomised clinical trial.
Ohguri T; Harima Y; Imada H; Sakurai H; Ohno T; Hiraki Y; Tuji K; Tanaka M; Terashima H
Int J Hyperthermia; 2018 Jun; 34(4):461-468. PubMed ID: 28679349
[TBL] [Abstract][Full Text] [Related]
6. HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy--a phase III study.
Zolciak-Siwinska A; Piotrkowicz N; Jonska-Gmyrek J; Nicke-Psikuta M; Michalski W; Kawczyńska M; Bijok M; Bujko K
Radiother Oncol; 2013 Nov; 109(2):194-9. PubMed ID: 23684588
[TBL] [Abstract][Full Text] [Related]
7. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
Sturdza A; Pötter R; Fokdal LU; Haie-Meder C; Tan LT; Mazeron R; Petric P; Šegedin B; Jurgenliemk-Schulz IM; Nomden C; Gillham C; McArdle O; Van Limbergen E; Janssen H; Hoskin P; Lowe G; Tharavichitkul E; Villafranca E; Mahantshetty U; Georg P; Kirchheiner K; Kirisits C; Tanderup K; Lindegaard JC
Radiother Oncol; 2016 Sep; 120(3):428-433. PubMed ID: 27134181
[TBL] [Abstract][Full Text] [Related]
8. The promise of image-guided brachytherapy of better clinical outcomes in treatment of cervical cancer: Does it deliver? An Indian scenario.
Tiwari R; Narayanan GS; Jayakumar V; Narayanan S; Vishwanathan B; Mandal SK; Babu S; Ramya V; George D
Gynecol Oncol; 2018 Sep; 150(3):420-425. PubMed ID: 30017538
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment of inoperable carcinomas of the uterine cervix with radiotherapy and regional hyperthermia. Results of a phase II trial.
Dinges S; Harder C; Wurm R; Buchali A; Blohmer J; Gellermann J; Wust P; Randow H; Budach V
Strahlenther Onkol; 1998 Oct; 174(10):517-21. PubMed ID: 9810319
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes using image-guided interstitial brachytherapy for definitive cervical cancer patients with high-risk clinical target volumes greater than 30 cc.
Wang C; Raince J; Swamy U; Park SJ; Zaide L; Mesko S; Demanes DJ; Kamrava M
Brachytherapy; 2018; 17(2):392-398. PubMed ID: 29128230
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer outcome prediction to high-dose rate brachytherapy using quantitative magnetic resonance imaging analysis of tumor response to external beam radiotherapy.
Minkoff D; Gill BS; Kang J; Beriwal S
Radiother Oncol; 2015 Apr; 115(1):78-83. PubMed ID: 25805517
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Image-guided Brachytherapy in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
Anticancer Res; 2019 Jun; 39(6):3015-3024. PubMed ID: 31177143
[TBL] [Abstract][Full Text] [Related]
13. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency.
Vasanthan A; Mitsumori M; Park JH; Zhi-Fan Z; Yu-Bin Z; Oliynychenko P; Tatsuzaki H; Tanaka Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):145-53. PubMed ID: 15629605
[TBL] [Abstract][Full Text] [Related]
14. Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.
Kamran SC; Manuel MM; Cho LP; Damato AL; Schmidt EJ; Tempany C; Cormack RA; Viswanathan AN
Gynecol Oncol; 2017 May; 145(2):284-290. PubMed ID: 28318644
[TBL] [Abstract][Full Text] [Related]
15. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
16. Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB "bulky".
Sreenivasa G; Hildebrandt B; Kümmel S; Jungnickel K; Cho CH; Tilly W; Böhmer D; Budach V; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1159-67. PubMed ID: 16979843
[TBL] [Abstract][Full Text] [Related]
17. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
Parker K; Gallop-Evans E; Hanna L; Adams M
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-based image-guided brachytherapy for cervical cancer: correlations between dose-volume parameters and clinical outcomes.
Kusada T; Toita T; Ariga T; Maemoto H; Hashimoto S; Shiina H; Kakinohana Y; Heianna J; Nagai Y; Kudaka W; Aoki Y; Murayama S
J Radiat Res; 2018 Jan; 59(1):67-76. PubMed ID: 29186565
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update.
Westermann A; Mella O; Van Der Zee J; Jones EL; Van Der Steen-Banasik E; Koper P; Uitterhoeve AL; De Wit R; Van Der Velden J; Burger C; Schem BC; Van Der Wilt C; Dahl O; Prosnitz LR; Van Tinteren H
Int J Hyperthermia; 2012; 28(6):549-53. PubMed ID: 22788973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]